MOCS3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.057200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.680200E-01
Normal-vs-Stage2
4.516000E-01
Normal-vs-Stage3
5.317600E-02
Normal-vs-Stage4
6.934200E-01
Stage1-vs-Stage2
8.385400E-01
Stage1-vs-Stage3
4.587600E-02
Stage1-vs-Stage4
9.751000E-01
Stage2-vs-Stage3
4.444000E-02
Stage2-vs-Stage4
9.014200E-01
Stage3-vs-Stage4
1.834970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.945000E-01
Normal-vs-AfricanAmerican
4.865200E-01
Normal-vs-Asian
9.074400E-01
Caucasian-vs-AfricanAmerican
8.516200E-01
Caucasian-vs-Asian
2.985400E-01
AfricanAmerican-vs-Asian
5.707400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.678400E-01
Normal-vs-Female
5.830400E-01
Male-vs-Female
2.550400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.403600E-01
Normal-vs-Age(41-60Yrs)
6.998800E-01
Normal-vs-Age(61-80Yrs)
4.348000E-01
Normal-vs-Age(81-100Yrs)
5.900200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.283400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.026400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.768800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.828400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.117800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.677800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.492610E-01
Normal-vs-Daily Drinker
3.542800E-01
Normal-vs-Weekly Drinker
7.091000E-01
Normal-vs-Occasional Drinker
8.312600E-01
Normal-vs-Social Drinker
7.182400E-01
Non Drinker-vs-Daily Drinker
5.011200E-01
Non Drinker-vs-Weekly Drinker
1.614230E-01
Non Drinker-vs-Occasional Drinker
1.359940E-03
Non Drinker-vs-Social Drinker
1.433640E-01
Daily Drinker-vs-Weekly Drinker
4.577800E-01
Daily Drinker-vs-Occasional Drinker
2.612000E-02
Daily Drinker-vs-Social Drinker
4.297600E-01
Weekly Drinker-vs-Occasional Drinker
2.812800E-01
Weekly Drinker-vs-Social Drinker
9.789600E-01
Occasional Drinker-vs-Social Drinker
2.879800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.162400E-01
Normal-vs-Grade 2
8.823000E-01
Normal-vs-Grade 3
9.477400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.005200E-01
Grade 1-vs-Grade 3
6.508800E-01
Grade 1-vs-Grade 4
9.162400E-01
Grade 2-vs-Grade 3
7.193800E-02
Grade 2-vs-Grade 4
8.823000E-01
Grade 3-vs-Grade 4
9.477400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.074800E-01
Normal-vs-NonDiabetic
6.249000E-01
Diabetic-vs-NonDiabetic
4.277600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.472600E-01
Normal-vs-NoPancreatitis
5.270400E-01
Pancreatitis-vs-NoPancreatitis
7.627200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.509800E-01
Normal-vs-N1
4.588800E-01
N0-vs-N1
9.490600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.755400E-01
Normal-vs-TP53-NonMutant
7.978000E-01
TP53-Mutant-vs-TP53-NonMutant
3.148200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
